title: Can thalidomide be effective to treat plasma cell leptomeningeal infiltration?
authors.forename: Perla
authors.initials: P
authors.lastname: Vicari
authors.forename: Christian
authors.initials: C
authors.lastname: Ribas
authors.forename: Manuella
authors.initials: M
authors.lastname: Sampaio
authors.forename: Adriano M
authors.initials: AM
authors.lastname: Arantes
authors.forename: Mihoko
authors.initials: M
authors.lastname: Yamamoto
authors.forename: João B Reis
authors.initials: JB
authors.lastname: Filho
authors.forename: Roberto A
authors.initials: RA
authors.lastname: Segreto
authors.forename: José Orlando
authors.initials: JO
authors.lastname: Bordin
authors.forename: Gisele W B
authors.initials: GW
authors.lastname: Colleoni
mesh_terms: D005260:Female; D006801:Humans; D008577:Meningeal Neoplasms / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D009101:Multiple Myeloma / Q000473:pathology*; D009361:Neoplasm Invasiveness; D010950:Plasma Cells / Q000473:pathology; D013792:Thalidomide / Q000008:administration & dosage*
chemical_list: D013792:Thalidomide